BACKGROUND: This study is aimed to investigate if there was increased risk of HBV acquisition among first graders in Taiwan during a 3-year follow-up period. METHODS: A total of 1545 healthy first graders, who were vaccinated against HBV in infancy, were recruited in 2005. All subjects were checked for hepatitis B surface antigens (HBsAg), antibodies to HBsAg (anti-HBs), and to the hepatitis B core antigen (anti-HBc). Nucleotide sequence of the "a" determinant of HBsAg was determined by polymerase chain reaction and direct sequencing in the HBsAg carriers. RESULTS: Among 1545 subjects, 0.78% were HBsAg seropositive, 54.30% were anti-HBs seropositive, and 1.68% anti-HBc seropositive. Three of the 10 HBV carriers (30%), whose HBV DNA were sequenced for the S gene, had surface antigen mutants at the "a" determinant. CONCLUSION: There were no new chronic HBV infections in this cohort of children for two consecutive years. HBV S gene vaccine escape mutants did exist in the vaccine-failure population, but they may not have made a major health impact. Copyright 2010 Elsevier Ltd. All rights reserved.
BACKGROUND: This study is aimed to investigate if there was increased risk of HBV acquisition among first graders in Taiwan during a 3-year follow-up period. METHODS: A total of 1545 healthy first graders, who were vaccinated against HBV in infancy, were recruited in 2005. All subjects were checked for hepatitis B surface antigens (HBsAg), antibodies to HBsAg (anti-HBs), and to the hepatitis B core antigen (anti-HBc). Nucleotide sequence of the "a" determinant of HBsAg was determined by polymerase chain reaction and direct sequencing in the HBsAg carriers. RESULTS: Among 1545 subjects, 0.78% were HBsAg seropositive, 54.30% were anti-HBs seropositive, and 1.68% anti-HBc seropositive. Three of the 10 HBV carriers (30%), whose HBV DNA were sequenced for the S gene, had surface antigen mutants at the "a" determinant. CONCLUSION: There were no new chronic HBV infections in this cohort of children for two consecutive years. HBV S gene vaccine escape mutants did exist in the vaccine-failure population, but they may not have made a major health impact. Copyright 2010 Elsevier Ltd. All rights reserved.
Authors: Timothy Na Archampong; Ceejay L Boyce; Margaret Lartey; Kwamena W Sagoe; Adjoa Obo-Akwa; Ernest Kenu; Jason T Blackard; Awewura Kwara Journal: Antivir Ther Date: 2016-05-11
Authors: Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard Journal: J Gen Virol Date: 2016-03-31 Impact factor: 3.891
Authors: Edgar T Overton; Somnuek Sungkanuparph; Michael Klebert; Michael Royal; Debra Demarco-Shaw; William G Powderly; Judith A Aberg Journal: Open Virol J Date: 2011-10-14
Authors: Motswedi Anderson; Simani Gaseitsiwe; Sikhulile Moyo; Matthijs J C Wessels; Terence Mohammed; Theresa K Sebunya; Eleanor A Powell; Joseph Makhema; Jason T Blackard; Richard Marlink; Max Essex; Rosemary M Musonda Journal: BMC Infect Dis Date: 2015-08-13 Impact factor: 3.090
Authors: Carlos Mario Jaramillo; Fernando de La Hoz; Alexandra Porras; Diana di Filippo; Luz Angela Choconta-Piraquive; Edra Payares; Neyla Montes; Maria-Cristina Navas Journal: PLoS One Date: 2017-10-10 Impact factor: 3.240